Moneycontrol PRO
HomeNewsOpinionCOVID-19 | Data privacy in these testing times

COVID-19 | Data privacy in these testing times

In these times when the needs of the many outweighs those of the few, ensuring that the rights of those few are not illegally violated remains critical as well

April 08, 2020 / 11:39 IST
Vikram Koppikar

In the popular motion picture Star Trek II: The Wrath of Khan, Spock famously states, “the needs of the many outweigh the needs of the few”. Today, as we are faced with the COVID-19 pandemic, a similar sense seems to prevail when making choices about matters relating to data privacy.

The COVID-19 outbreak has caused the deaths of more than 82,000 globally, and has resulted in a global lockdown of sorts. Given the manner in which the virus spreads, there has been widespread panic in ‘distancing’ oneself from those affected with the disease. From reports of violence against Indian medical professionals treating patients, to a reported increase in weapon sales in the United States, public sentiment, it appears, is bent on discovering those infected or in contact with the virus to keep themselves away from such populace.

As medical/health-related information is covered globally under privacy laws, there is an unprecedented demand to do away with privacy of those ‘affected’ by the disease, or in Spock’s words, “the needs of the many” outweighing those of the “few”.

From Google’s hosting of a website collating information about affected persons in the US, to creation of the Arogya Setu App, which informs users about their proximity to affected persons on the basis of general data collected, mass collection of ‘health’-related data has become the new norm.

Section 3(36) of the Personal Data Protection Bill, 2019 classifies ‘health data’ as sensitive personal information, and imposes restrictions on the cross border flow in regards to such data. These restrictions are waived in event of a ‘medical emergency’ which affects the health of the data subject or other individuals as detailed under Section 12(d) of the Bill. The Epidemic Diseases Act, 1897 allows the government to take steps ‘necessary’ to curtail the spread of disease (which may arguably infringe upon a person’s privacy).

COVID-19 Vaccine

Frequently Asked Questions

View more
How does a vaccine work?

A vaccine works by mimicking a natural infection. A vaccine not only induces immune response to protect people from any future COVID-19 infection, but also helps quickly build herd immunity to put an end to the pandemic. Herd immunity occurs when a sufficient percentage of a population becomes immune to a disease, making the spread of disease from person to person unlikely. The good news is that SARS-CoV-2 virus has been fairly stable, which increases the viability of a vaccine.

How many types of vaccines are there?

There are broadly four types of vaccine — one, a vaccine based on the whole virus (this could be either inactivated, or an attenuated [weakened] virus vaccine); two, a non-replicating viral vector vaccine that uses a benign virus as vector that carries the antigen of SARS-CoV; three, nucleic-acid vaccines that have genetic material like DNA and RNA of antigens like spike protein given to a person, helping human cells decode genetic material and produce the vaccine; and four, protein subunit vaccine wherein the recombinant proteins of SARS-COV-2 along with an adjuvant (booster) is given as a vaccine.

What does it take to develop a vaccine of this kind?

Vaccine development is a long, complex process. Unlike drugs that are given to people with a diseased, vaccines are given to healthy people and also vulnerable sections such as children, pregnant women and the elderly. So rigorous tests are compulsory. History says that the fastest time it took to develop a vaccine is five years, but it usually takes double or sometimes triple that time.

View more
Show

In the absence of privacy legislation, and perhaps armed with powers from the above mentioned Act, the Karnataka government recently published a database of persons affected with the disease, which, in turn, led to reports of threats being made against persons declared affected. The Delhi government too handed over a list of patients in quarantine to the Delhi Police to ensure that they abided by such quarantine rules.

What hope lies to protect privacy in these testing times?

The landmark 2017 judgment of KS Puttaswamy, where privacy was upheld as a ‘fundamental right’, requires a threefold test to ensure that any act by the State does not violate such a right. First, the action must be sanctioned by law (legality). Second, the action must be necessary for a legitimate aim (need). Third, the action (interference in privacy) must be proportionate to the need for such action (proportionality).

J Sikri, in the Aadhaar judgment, built upon the proportionality test decided in Puttaswamy and provided further ‘sub-provisions’ in deciding it. It was observed that the interference must have a legitimate goal (legitimacy stage); that it must constitute a suitable mean of achieving the goal (suitability stage); that there must not be any less restrictive but equally effective alternative (necessity stage), and; that the measure must not have a disproportionate impact on the right holder (balancing stage).

Let’s examine the government’s actions in collating and making public the medical records of COVID-19 patients against these four ‘sub provisions’. While it may be argued that the test of ‘legitimacy’ has been fulfilled in preventing further casualties, it could be argued that alternative options such as anonymising patient details could have been followed in the ‘necessity stage’, as the resultant deprivation of privacy certainly failed the ‘balancing stage’.

With the coronavirus pandemic showing no signs of abatement, is India poised to enter into a surveillance state? Previously there was mention of an Automated Facial Recognition System (AFRS) system to be put in place by the National Criminal Record Bureau (NCRB), which would source data from various streams, including Aadhaar records, passport details and the like, to be able to track down an individual. While this system was envisioned to track down criminals, is it too farfetched to envision its usage in tracking affected persons?

Furthermore, in the absence of a privacy legislation, it is shuddering to envision a scenario where the AFRS-derived data, complete with facial features, is leaked. While Spock may have been correct in upholding the needs of the many, ensuring that the rights of the one is not illegally violated remains critical as well.

Vikram Koppikar is Senior Legal Manager, Tata Consultancy Services, Views are personal.
Invite your friends and family to sign up for MC Tech 3, our daily newsletter that breaks down the biggest tech and startup stories of the day

Moneycontrol Contributor
Moneycontrol Contributor
first published: Apr 8, 2020 11:39 am

Discover the latest Business News, Sensex, and Nifty updates. Obtain Personal Finance insights, tax queries, and expert opinions on Moneycontrol or download the Moneycontrol App to stay updated!

Subscribe to Tech Newsletters

  • On Saturdays

    Find the best of Al News in one place, specially curated for you every weekend.

  • Daily-Weekdays

    Stay on top of the latest tech trends and biggest startup news.

Advisory Alert: It has come to our attention that certain individuals are representing themselves as affiliates of Moneycontrol and soliciting funds on the false promise of assured returns on their investments. We wish to reiterate that Moneycontrol does not solicit funds from investors and neither does it promise any assured returns. In case you are approached by anyone making such claims, please write to us at grievanceofficer@nw18.com or call on 02268882347